Open main menu
Search Ctrl + K
Sign up for free
Loading...
Xenetic Biosciences, Inc.
Watch
Pharmaceutical Preparations
NASDAQ.XBIO
945 Concord St., Framingham, MA, 01701
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Latest Filings – Ownership
4
Parslow James F
21 Jun 24
SC 13D/A
Amended Statement Of Beneficial Ownership Of More Than 5%.
18 Mar 24
3
Mizrahy Moshe
18 Dec 23
4
Mizrahy Moshe
18 Dec 23
4
Lockshin Curtis
13 Dec 23
4
Parslow James F
13 Dec 23
4
Eisenberg Jeffrey F
13 Dec 23
4
Logal Adam
08 Dec 23
4
Kornberg Roger D.
08 Dec 23
4
Callaway James Eric
08 Dec 23
4
Vinogradov Alexey Andreevich
08 Dec 23
4
Dastoor Firdaus J.
08 Dec 23
4
Borisenko Grigory G.
08 Dec 23
SC 13D/A
Amended Statement Of Beneficial Ownership Of More Than 5%.
18 Sep 23
SC 13D
Acquired More Than 5% Ownership Of Any Class Of A Company's Securities.
15 Jun 23
4
Logal Adam
09 Dec 22
4
Borisenko Grigory G.
09 Dec 22
4
Vinogradov Alexey Andreevich
09 Dec 22
4
Kornberg Roger D.
09 Dec 22
4
Callaway James Eric
09 Dec 22
Latest Filings – Non-Ownership
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
14 Aug 24
10-Q
Quarterly Filing
13 Aug 24
25-NSE
Notification Filed By National Securities Exchanges Of The Removal From Listing And Registration Of Matured, Redeemed Or Retired Securities.
18 Jul 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers
21 Jun 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Regulation Fd Disclosure, Financial Statements And Exhibits
22 May 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
10 May 24
10-Q
Quarterly Filing
09 May 24
10-K/A
Fiscal Year 2023
26 Apr 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
22 Mar 24
10-K
Fiscal Year 2023
21 Mar 24
8-K
Regulation Fd Disclosure
12 Feb 24
8-K
Submission Of Matters To A Vote Of Security Holders
08 Dec 23
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
13 Nov 23
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
13 Nov 23
10-Q
Quarterly Filing
09 Nov 23
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
11 Aug 23
10-Q
Quarterly Filing
10 Aug 23
8-K
Regulation Fd Disclosure, Financial Statements And Exhibits
06 Jun 23
8-K
Other Events
02 Jun 23
10-Q
Quarterly Filing
11 May 23